Nascent Biotech Inc (OTCMKTS:NBIO) Stock In Focus After Recent Development
It was a fairly good day in the markets for investors in Nascent Biotech Inc (OTCMKTS:NBIO) as the stock ended up with gains of as much as 4% for the day following an announcement from the company. The clinical stage biotech firm announced yesterday that it had been successful in concluding the fourth cohort in dosing patients for the Phase 1 trial for the evaluation of its product Pritumumab. Trading…